Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹6,891 Cr
up ₹421 Cr vs Dec 2023
- Stocks held
- 32
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In January 2024 it disclosed 32 stocks worth ₹6,891 Cr, up ₹421 Cr from Dec 2023. Its largest positions were Sun Pharmaceutical Industries Limited (13.5%), Lupin Limited (8.3%), Cipla Limited (6.1%); the ten largest together made up 58.9% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 77.4% of its equity. Cash and debt stood at 0.8%. Compared with Dec 2023 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
81%
Top-10 weight is higher than 81% of peers
Breadth
18%
Holds more stocks than 18% of peers
Cash
11%
Holds more cash than 11% of peers
What these mean: concentration · cash
Holdings in January 2024
Download CSVEvery line the fund disclosed, with the change against Dec 2023. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 13.50% | up 0.73 pts | ₹930 Cr | up ₹104 Cr | Added |
| Lupin Limited | 8.31% | up 0.53 pts | ₹573 Cr | up ₹69.4 Cr | Added |
| Cipla Limited | 6.08% | up 0.11 pts | ₹419 Cr | up ₹32.5 Cr | Added |
| Apollo Hospitals Enterprise Limited | 5.98% | up 0.26 pts | ₹412 Cr | up ₹42.1 Cr | Added |
| Dr. Reddy's Laboratories Limited | 4.89% | down 0.04 pts | ₹337 Cr | up ₹17.8 Cr | Added |
| Gland Pharma Limited | 4.83% | down 0.23 pts | ₹333 Cr | up ₹5.4 Cr | Added |
| Divi's Laboratories Limited | 4.53% | up <0.01 pts | ₹312 Cr | up ₹19.2 Cr | Added |
| Aurobindo Pharma Limited | 3.84% | down 0.01 pts | ₹265 Cr | up ₹15.3 Cr | Added |
| JB Chemicals & Pharmaceuticals Limited | 3.63% | down 0.10 pts | ₹250 Cr | up ₹8.8 Cr | Added |
| Narayana Hrudayalaya Limited | 3.34% | up 0.09 pts | ₹230 Cr | up ₹20.1 Cr | Added |
| Zydus Lifesciences Limited | 3.31% | up 0.12 pts | ₹228 Cr | up ₹21.5 Cr | Added |
| MedPlus Health Services Limited | 3.20% | down 0.37 pts | ₹220 Cr | down ₹10.5 Cr | Trimmed |
| Ajanta Pharma Limited | 3.05% | down 0.06 pts | ₹211 Cr | up ₹8.8 Cr | Added |
| Vijaya Diagnostic Centre Limited | 3.03% | down 0.27 pts | ₹209 Cr | down ₹4.8 Cr | Trimmed |
| Sanofi India Limited | 2.97% | up 0.02 pts | ₹204 Cr | up ₹14.1 Cr | Added |
| Abbott India Limited | 2.87% | up 0.17 pts | ₹198 Cr | up ₹23.3 Cr | Added |
| GlaxoSmithKline Pharmaceuticals Limited | 2.79% | up 0.28 pts | ₹192 Cr | up ₹30 Cr | Added |
| Alkem Laboratories Limited | 2.74% | down 0.30 pts | ₹189 Cr | down ₹7.8 Cr | Trimmed |
| Mankind Pharma Limited | 2.61% | down 0.39 pts | ₹180 Cr | down ₹14.3 Cr | Trimmed |
| Torrent Pharmaceuticals Limited | 2.22% | up 0.07 pts | ₹153 Cr | up ₹13.6 Cr | Added |
| Fortis Healthcare Limited | 2.19% | down 0.07 pts | ₹151 Cr | up ₹4.4 Cr | Added |
| Pfizer Limited | 2.00% | up 0.06 pts | ₹138 Cr | up ₹12.4 Cr | Added |
| Thyrocare Technologies Limited | 1.56% | down 0.19 pts | ₹108 Cr | down ₹5.9 Cr | Trimmed |
| Syngene International Limited | 1.22% | up 0.46 pts | ₹84.4 Cr | up ₹35.2 Cr | Added |
| Concord Biotech Limited | 1.06% | down 0.08 pts | ₹73 Cr | down ₹80 L | Trimmed |
| Orchid Pharma Limited | 1.05% | up 0.11 pts | ₹72.4 Cr | up ₹11.3 Cr | Added |
| Indoco Remedies Limited | 0.99% | down 0.13 pts | ₹68.3 Cr | down ₹4.2 Cr | Trimmed |
| Cash, TREPS & receivables | 0.77% | down 0.69 pts | ₹53.3 Cr | down ₹41.3 Cr | Trimmed |
| Metropolis Healthcare Limited | 0.49% | down 0.05 pts | ₹34.1 Cr | down ₹96 L | Trimmed |
| Jubilant Pharmova Limited | 0.46% | down 0.01 pts | ₹31.4 Cr | up ₹1.4 Cr | Added |
| Healthcare Global Enterprises Limited | 0.22% | down 0.01 pts | ₹14.9 Cr | up ₹26 L | Added |
| Tarsons Products Limited | 0.16% | down 0.02 pts | ₹10.8 Cr | down ₹96 L | Trimmed |
| AstraZeneca Pharma India Limited | 0.11% | up 0.01 pts | ₹7.6 Cr | up ₹1.3 Cr | Added |
What changed, Dec 2023 to Jan 2024
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹104 Cr (+0.73% pts)
- Lupin Limitedup ₹69.4 Cr (+0.53% pts)
- Apollo Hospitals Enterprise Limitedup ₹42.1 Cr (+0.26% pts)
- Syngene International Limitedup ₹35.2 Cr (+0.46% pts)
- Cipla Limited ₹32.5 Cr (+0.11% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Dec 2023, the weight rose most in Pharmaceuticals & Biotechnology (+0.5 pts), and fell most in Retailing (−0.4 pts) and Pharmaceuticals (−0.1 pts).
- Pharmaceuticals & Biotechnology77.0% → 77.4%+0.5 pts
- Retailing3.6% → 3.2%−0.4 pts
- Pharmaceuticals1.1% → 1.0%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jan 2021 | Jan 2023 | Jul 2023 | Oct 2023 | Dec 2023 | Jan 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 78.9% | 78.2% | 77.3% | 77.2% | 77.0% | 77.4% |
| Healthcare Services | 18.6% | 18.9% | 17.8% | 17.0% | 18.1% | 18.2% |
| Retailing | — | 1.2% | 3.5% | 4.6% | 3.6% | 3.2% |
| Pharmaceuticals | 2.5% | 1.4% | 1.1% | 1.1% | 1.1% | 1.0% |
| Healthcare Equipment & Supplies | — | 0.4% | 0.3% | 0.2% | 0.2% | 0.2% |
Allocation in Jan 2024change vs Dec 2023
- Pharmaceuticals & Biotechnology (21)77.4%▲ 0.5 pts
- Healthcare Services (8)18.2%▲ 0.1 pts
- Retailing (1)3.2%▼ 0.4 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jan 2024
0.8%
▼ 0.7 pts vs Dec 2023
- Cash alone
- 0.8%
- cash and net receivables
- A year earlier
- 0.7%
- Jan 2023 · now ▲ 0.1 pts
- Last 12 months
- 0.5% – 3.9%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.